Immuno-Biological Laboratories CoTSE:4570 +0.84%59 Median PS Value is 円791.01 as of Jun. 30, 2026, which is 100% below its 10-year median of 1.01. GuruFocus rates TSE:4570 with a GF Score™ of 59/100 and a GF Value™ of 円576.66 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 276 Biotechnology companies, Immuno-Biological Laboratories Co ranks worse than 80.43% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Immuno-Biological Laboratories Co's Median PS Value or its related term are showing as below:
TSE:4570'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.58 Med: 1.01 Max: 1.99
Current: 1.22
During the past 13 years, the highest Price to Median PS Value of Immuno-Biological Laboratories Co was 1.99. The lowest was 0.58. And the median was 1.01.
TSE:4570's Price-to-Median-PS-Value is ranked worse than 80.43% of 276
companies
in the Biotechnology industry
Industry Median: 0.63
vs TSE:4570: 1.22
Immuno-Biological Laboratories Co (TSE:4570) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Immuno-Biological Laboratories Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
963.00
/
791.01
=
1.22
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immuno-Biological Laboratories Co Median PS Value Related Terms
Immuno-Biological Laboratories Co Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immuno-Biological Laboratories Co Median PS Value Chart
TSE:4570 vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, Immuno-Biological Laboratories Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Immuno-Biological Laboratories Co Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Immuno-Biological Laboratories Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 7.3301.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Immuno-Biological Laboratories Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円107.912.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immuno-Biological Laboratories Co (TSE:4570) has a Median PS Value of 円791.01 as of Jun. 30, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Immuno-Biological Laboratories Co and its competitors. This is 78218% above median its historical median of 1.01. Over the past decade, Immuno-Biological Laboratories Co's Median PS Value has ranged from 0.58 to 1.99. According to the industry distribution chart, Immuno-Biological Laboratories Co ranks #222 out of 276 companies in the Biotechnology industry, placing it in the top 80.4%.
Is Immuno-Biological Laboratories Co's Median PS Value too high?
Immuno-Biological Laboratories Co's current Median PS Value of 円791.01 is 78218% above median its 10-year median of 1.01. Over the past 10 years, this metric has ranged from a low of 0.58 to a high of 1.99. Based on the distribution chart, Immuno-Biological Laboratories Co ranks #222 out of 276 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Immuno-Biological Laboratories Co has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Immuno-Biological Laboratories Co's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Immuno-Biological Laboratories Co ranks #222 out of 276 companies for Median PS Value. This places Immuno-Biological Laboratories Co in the lower half of its industry. The industry median Median PS Value is 0.63. Historically, Immuno-Biological Laboratories Co's own Median PS Value has ranged from 0.58 to 1.99 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.63, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Immuno-Biological Laboratories Co and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Immuno-Biological Laboratories Co's current Median PS Value is 円791.01, which is 78218% above median its own 10-year median of 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immuno-Biological Laboratories Co stock overvalued right now?
Based on GuruFocus' analysis, Immuno-Biological Laboratories Co (TSE:4570) is currently considered Significantly Overvalued. The stock's GF Value™ is 円576.66, compared to a current price of 円963.00 — trading 67% above its estimated fair value. The current Median PS Value is 円791.01, which is 78218% above median its 10-year median of 1.01. Immuno-Biological Laboratories Co's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Immuno-Biological Laboratories Co (TSE:4570), the current Median PS Value is 円791.01 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Immuno-Biological Laboratories Co (TSE:4570) Overvalued in 2026?
Based on GuruFocus' analysis, Immuno-Biological Laboratories Co stock appears to be overvalued.
The current stock price of 円963.00 is trading 67% above its estimated GF Value™ of 円576.66.
GuruFocus considers Immuno-Biological Laboratories Co to be Significantly Overvalued.
Key valuation signals for TSE:4570:
Median PS Value: 円791.01 (78218% above median its 10-year median of 1.01)
GF Value™: 円576.66 vs. price of 円963.00 (67% above fair value)
No single metric tells the full story. See the TSE:4570 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Immuno-Biological Laboratories Co Business Description
Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.
59GF Score
Get the complete analysis for TSE:4570
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4570 has been successfully added to your 
